Home › NDC Lookup › RxCUI directory › RxCUI 1117522

Colistin 75 MG/ML Injectable Solution — RxCUI 1117522

RxNorm drug concept · Semantic clinical drug
RxCUI 1117522 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1117522
Official nameColistin 75 MG/ML Injectable Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascolistin (as colistimethate sodium) 75 MG/ML Injectable Solution
FDA products mapped6
Package NDCs mapped9
Reported Medicaid activity (SDUD)894 prescriptions · 9 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Colistin 75 MG/ML Injectable Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Colistin 75 MG/ML Injectable Solution RxCUI 1117522

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Colistin 2709
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Coly Mycin M 216159
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Colistin Injectable Solution 1117521
    • Colistin Injectable Product 1155492
    • Colistin Injectable Solution [Coly Mycin M] 1117524
    • Coly Mycin M Injectable Product 1166871
    • Injectable Solution 316949
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Colistin 75 MG/ML SCDC · 1117520
  • Colistin Injectable Solution SCDF · 1117521
  • Colistin Injectable Product SCDG · 1155492

Brand-Name Concepts

📦 FDA Products & Package NDCs

6 products · 9 package NDCs
9 package NDCs map to RxCUI 1117522 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00143-9443-01 1 VIAL, GLASS in 1 CARTON (0143-9443-01) / 1 INJECTION, POW... Colistimethate Hikma Pharmaceuticals USA Inc. 2026-03-04
00143-9443-12 12 VIAL, GLASS in 1 CARTON (0143-9443-12) / 1 INJECTION, PO... Colistimethate Hikma Pharmaceuticals USA Inc. 2026-03-04
23155-0193-31 1 VIAL, GLASS in 1 CARTON (23155-193-31) / 4 mL in 1 VIAL,... COLISTIMETHATE SODIUM Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2021-09-09
23155-0193-41 12 VIAL, GLASS in 1 CARTON (23155-193-41) / 4 mL in 1 VIAL,... COLISTIMETHATE SODIUM Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2021-09-09
42023-0107-01 1 VIAL in 1 CARTON (42023-107-01) / 2 mL in 1 VIAL Coly-Mycin M Par Health USA, LLC 2007-11-01
63323-0393-06 1 VIAL in 1 BOX (63323-393-06) / 2 mL in 1 VIAL Colistimethate Fresenius Kabi USA, LLC 2009-12-04
70594-0023-01 1 VIAL, GLASS in 1 VIAL (70594-023-01) / 1 INJECTION, POWDE... Colistimethate Xellia Pharmaceuticals USA LLC 2018-10-01
70594-0023-04 12 VIAL, GLASS in 1 CARTON (70594-023-04) / 1 INJECTION, PO... Colistimethate Xellia Pharmaceuticals USA LLC 2018-10-01
70594-0023-09 1 VIAL in 1 CARTON (70594-023-09) / 1 INJECTION, POWDER, FO... Colistimethate Xellia Pharmaceuticals USA LLC 2022-02-20
Observed labelers: Xellia Pharmaceuticals USA LLC (3) · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (2) · Hikma Pharmaceuticals USA Inc. (2) · Fresenius Kabi USA, LLC (1) · Par Health USA, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J0770 Colistimethate sodium inj 7 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.